Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-06-29 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-12-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Parties | ANOBRI PHARMACEUTICALS US, LLC | ||
| Patents | 7,284,474; 7,396,341; 7,837,235; 7,896,264; 8,733,341; 9,027,967 | ||
| Attorneys | CHARLES MICHAEL LIZZA | ||
| Firms | Saul Ewing LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC
Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-06-29 | External link to document | |||
| 2023-06-29 | 48 | 1 - Terminate Deadlines AND Order | ANDAFFIRMATIVE DEFENSES REGARDING U.S. PATENT NOS. 7,284,474 AND 7,896,264 without prejudice. Signed … 18 December 2023 2:23-cv-03531 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
